-
1
-
-
84871211326
-
Pathobiology of pulmonary arterial hypertension and right ventricular failure
-
Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. 2012;40:1555-1565
-
(2012)
Eur Respir J.
, vol.40
, pp. 1555-1565
-
-
Voelkel, N.F.1
Gomez-Arroyo, J.2
Abbate, A.3
Bogaard, H.J.4
Nicolls, M.R.5
-
2
-
-
0025837793
-
Survival in patients with primary pulmonary hypertension Results from a national prospective registry
-
D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343-349
-
(1991)
Ann Intern Med
, vol.115
, pp. 343-349
-
-
D'Alonzo, G.E.1
Barst, R.J.2
Ayres, S.M.3
Bergofsky, E.H.4
Brundage, B.H.5
Detre, K.M.6
Fishman, A.P.7
Goldring, R.M.8
Groves, B.M.9
Kernis, J.T.10
-
3
-
-
29244486514
-
Autoimmunity and pulmonary hypertension: A perspective
-
Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: A perspective. Eur Respir J. 2005;26:1110-1118
-
(2005)
Eur Respir J.
, vol.26
, pp. 1110-1118
-
-
Nicolls, M.R.1
Taraseviciene-Stewart, L.2
Rai, P.R.3
Badesch, D.B.4
Voelkel, N.F.5
-
4
-
-
84861341904
-
Pharmacology and therapeutic potential of interferons
-
George PM, Badiger R, Alazawi W, Foster GR, Mitchell JA. Pharmacology and therapeutic potential of interferons. Pharmacol Ther. 2012;135:44-53
-
(2012)
Pharmacol Ther
, vol.135
, pp. 44-53
-
-
George, P.M.1
Badiger, R.2
Alazawi, W.3
Foster, G.R.4
Mitchell, J.A.5
-
5
-
-
0037346638
-
Vascular events associated with alpha interferon therapy
-
Al-Zahrani H, Gupta V, Minden MD, Messner HA, Lipton JH. Vascular events associated with alpha interferon therapy. Leuk Lymphoma. 2003;44:471-475
-
(2003)
Leuk Lymphoma
, vol.44
, pp. 471-475
-
-
Al-Zahrani, H.1
Gupta, V.2
Minden, M.D.3
Messner, H.A.4
Lipton, J.H.5
-
6
-
-
24944447115
-
Long-Term therapy of interferon-Alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: A case report
-
Jochmann N, Kiecker F, Borges AC, Hofmann MA, Eddicks S, Sterry W, Baumann G, Trefzer U. Long-Term therapy of interferon-Alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: A case report. Cardiovasc Ultrasound. 2005;3:26
-
(2005)
Cardiovasc Ultrasound
, vol.3
, pp. 26
-
-
Jochmann, N.1
Kiecker, F.2
Borges, A.C.3
Hofmann, M.A.4
Eddicks, S.5
Sterry, W.6
Baumann, G.7
Trefzer, U.8
-
7
-
-
67649336879
-
Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: A case report
-
Ledinek AH, Jazbec SS, Drinovec I, Rot U. Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: A case report. Mult Scler. 2009;15:885-886
-
(2009)
Mult Scler
, vol.15
, pp. 885-886
-
-
Ledinek, A.H.1
Jazbec, S.S.2
Drinovec, I.3
Rot, U.4
-
8
-
-
77954424766
-
Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C
-
Dhillon S, Kaker A, Dosanjh A, Japra D, Vanthiel DH. Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C. Dig Dis Sci. 2010;55:1785-1790
-
(2010)
Dig Dis Sci
, vol.55
, pp. 1785-1790
-
-
Dhillon, S.1
Kaker, A.2
Dosanjh, A.3
Japra, D.4
Vanthiel, D.H.5
-
9
-
-
84875216158
-
Decline in pulmonary function during chronic hepatitis c virus therapy with modified interferon alfa and ribavirin
-
Foster GR, Zeuzem S, Pianko S, Sarin SK, Piratvisuth T, Shah S, Andreone P, Sood A, Chuang WL, Lee CM, George J, Gould M, Flisiak R, Jacobson IM, Komolmit P, Thongsawat S, Tanwandee T, Rasenack J, Sola R, Messina I, Yin Y, Cammarata S, Feutren G, Brown KK. Decline in pulmonary function during chronic hepatitis c virus therapy with modified interferon alfa and ribavirin. J Viral Hepat. 2013;20: E115-e123
-
(2013)
J Viral Hepat
, vol.20
-
-
Foster, G.R.1
Zeuzem, S.2
Pianko, S.3
Sarin, S.K.4
Piratvisuth, T.5
Shah, S.6
Andreone, P.7
Sood, A.8
Chuang, W.L.9
Lee, C.M.10
George, J.11
Gould, M.12
Flisiak, R.13
Jacobson, I.M.14
Komolmit, P.15
Thongsawat, S.16
Tanwandee, T.17
Rasenack, J.18
Sola, R.19
Messina, I.20
Yin, Y.21
Cammarata, S.22
Feutren, G.23
Brown, K.K.24
more..
-
10
-
-
84879750264
-
Decline in pulmonary function during chronic hepatitis c virus therapy with modified interferon alfa and ribavirin therapy
-
George PM, Mitchell JA. Decline in pulmonary function during chronic hepatitis c virus therapy with modified interferon alfa and ribavirin therapy. J Viral Hepat. 2013;20:592
-
(2013)
J Viral Hepat
, vol.20
, pp. 592
-
-
George, P.M.1
Mitchell, J.A.2
-
11
-
-
84878087571
-
Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity
-
George PM, Cunningham ME, Galloway-Phillipps N, Badiger R, Alazawi W, Foster GR, Mitchell JA. Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity. Pulm Circ. 2012;2:501-504
-
(2012)
Pulm Circ
, vol.2
, pp. 501-504
-
-
George, P.M.1
Cunningham, M.E.2
Galloway-Phillipps, N.3
Badiger, R.4
Alazawi, W.5
Foster, G.R.6
Mitchell, J.A.7
-
12
-
-
0032959132
-
Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: Evidence for intracellular endothelin-converting enzyme
-
Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, Warner TD. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: Evidence for intracellular endothelin-converting enzyme. Mol Pharmacol. 1999;55:902-909
-
(1999)
Mol Pharmacol
, vol.55
, pp. 902-909
-
-
Woods, M.1
Mitchell, J.A.2
Wood, E.G.3
Barker, S.4
Walcot, N.R.5
Rees, G.M.6
Warner, T.D.7
-
13
-
-
69949159203
-
Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites
-
Wort SJ, Ito M, Chou PC, Mc Master SK, Badiger R, Jazrawi E, de Souza P, Evans TW, Mitchell JA, Pinhu L, Ito K, Adcock IM. Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites. J Biol Chem. 2009;284:24297-24305
-
(2009)
J Biol Chem
, vol.284
, pp. 24297-24305
-
-
Wort, S.J.1
Ito, M.2
Chou, P.C.3
Mc Master, S.K.4
Badiger, R.5
Jazrawi, E.6
De Souza, P.7
Evans, T.W.8
Mitchell, J.A.9
Pinhu, L.10
Ito, K.11
Adcock, I.M.12
-
14
-
-
0026042115
-
Primary pulmonary hypertension in HIV infection
-
Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100:1268-1271
-
(1991)
Chest
, vol.100
, pp. 1268-1271
-
-
Speich, R.1
Jenni, R.2
Opravil, M.3
Pfab, M.4
Russi, E.W.5
-
15
-
-
0043074631
-
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
-
Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246-2255
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2246-2255
-
-
Mayes, M.D.1
Lacey Jr., J.V.2
Beebe-Dimmer, J.3
Gillespie, B.W.4
Cooper, B.5
Laing, T.J.6
Schottenfeld, D.7
-
16
-
-
0018102555
-
Pulmonary vascular changes in scleroderma
-
Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med. 1978;64:998-1004
-
(1978)
Am J Med
, vol.64
, pp. 998-1004
-
-
Young, R.H.1
Mark, G.J.2
-
17
-
-
0142187600
-
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach
-
Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis. 2003;62:1088-1093
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1088-1093
-
-
Mukerjee, D.1
St George, D.2
Coleiro, B.3
Knight, C.4
Denton, C.P.5
Davar, J.6
Black, C.M.7
Coghlan, J.G.8
-
18
-
-
77954965596
-
Type I interferon system activation and association with disease manifestations in systemic sclerosis
-
Eloranta ML, Franck-Larsson K, Lövgren T, Kalamajski S, Rönnblom A, Rubin K, Alm GV, Rönnblom L. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis. 2010;69:1396-1402
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1396-1402
-
-
Eloranta, M.L.1
Franck-Larsson, K.2
Lövgren, T.3
Kalamajski, S.4
Rönnblom, A.5
Rubin, K.6
Alm, G.V.7
Rönnblom, L.8
-
19
-
-
79958031292
-
Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-Associated pulmonary arterial hypertension
-
Christmann RB, Hayes E, Pendergrass S, Padilla C, Farina G, Affandi AJ, Whitfield ML, Farber HW, Lafyatis R. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-Associated pulmonary arterial hypertension. Arthritis Rheum. 2011;63: 1718-1728
-
(2011)
Arthritis Rheum
, vol.63
, pp. 1718-1728
-
-
Christmann, R.B.1
Hayes, E.2
Pendergrass, S.3
Padilla, C.4
Farina, G.5
Affandi, A.J.6
Whitfield, M.L.7
Farber, H.W.8
Lafyatis, R.9
-
20
-
-
4344697343
-
A new era in the management of pulmonary arterial hypertension related to scleroderma: Endothelin receptor antagonism
-
Hachulla E, Coghlan JG. A new era in the management of pulmonary arterial hypertension related to scleroderma: Endothelin receptor antagonism. Ann Rheum Dis. 2004;63:1009-1014
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1009-1014
-
-
Hachulla, E.1
Coghlan, J.G.2
-
21
-
-
79955542915
-
A diverse range of gene products are effectors of the type I interferon antiviral response
-
Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481-485
-
(2011)
Nature
, vol.472
, pp. 481-485
-
-
Schoggins, J.W.1
Wilson, S.J.2
Panis, M.3
Murphy, M.Y.4
Jones, C.T.5
Bieniasz, P.6
Rice, C.M.7
-
22
-
-
0027315862
-
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
-
Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993;177:1809-1814
-
(1993)
J Exp Med
, vol.177
, pp. 1809-1814
-
-
Taub, D.D.1
Lloyd, A.R.2
Conlon, K.3
Wang, J.M.4
Ortaldo, J.R.5
Harada, A.6
Matsushima, K.7
Kelvin, D.J.8
Oppenheim, J.J.9
-
23
-
-
3242765880
-
Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome
-
Hildebrandt GC, Corrion LA, Olkiewicz KM, Lu B, Lowler K, Duffner UA, Moore BB, Kuziel WA, Liu C, Cooke KR. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol. 2004;173:2050-2059
-
(2004)
J Immunol
, vol.173
, pp. 2050-2059
-
-
Hildebrandt, G.C.1
Corrion, L.A.2
Olkiewicz, K.M.3
Lu, B.4
Lowler, K.5
Duffner, U.A.6
Moore, B.B.7
Kuziel, W.A.8
Liu, C.9
Cooke, K.R.10
-
24
-
-
7244242362
-
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood
-
Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104:2752-2760
-
(2004)
Blood
, vol.104
, pp. 2752-2760
-
-
Ingram, D.A.1
Mead, L.E.2
Tanaka, H.3
Meade, V.4
Fenoglio, A.5
Mortell, K.6
Pollok, K.7
Ferkowicz, M.J.8
Gilley, D.9
Yoder, M.C.10
-
25
-
-
84878218994
-
Cellular and molecular basis of von Willebrand disease: Studies on blood outgrowth endothelial cells
-
Starke RD, Paschalaki KE, Dyer CE, Harrison-Lavoie KJ, Cutler JA, McKinnon TA, Millar CM, Cutler DF, Laffan MA, Randi AM. Cellular and molecular basis of von Willebrand disease: Studies on blood outgrowth endothelial cells. Blood. 2013;121:2773-2784
-
(2013)
Blood
, vol.121
, pp. 2773-2784
-
-
Starke, R.D.1
Paschalaki, K.E.2
Dyer, C.E.3
Harrison-Lavoie, K.J.4
Cutler, J.A.5
McKinnon, T.A.6
Millar, C.M.7
Cutler, D.F.8
Laffan, M.A.9
Randi, A.M.10
-
26
-
-
0035942990
-
Sildenafil inhibits hypoxia-induced pulmonary hypertension
-
Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104:424-428
-
(2001)
Circulation
, vol.104
, pp. 424-428
-
-
Zhao, L.1
Mason, N.A.2
Morrell, N.W.3
Kojonazarov, B.4
Sadykov, A.5
Maripov, A.6
Mirrakhimov, M.M.7
Aldashev, A.8
Wilkins, M.R.9
-
27
-
-
84867302707
-
Effect of different interferona2 preparations on IP10 and ET-1 release from human lung cells
-
Badiger R, Mitchell JA, Gashaw H, Galloway-Phillipps NA, Foser S, Tatsch F, Singer T, Hansel TT, Manigold T. Effect of different interferona2 preparations on IP10 and ET-1 release from human lung cells. PLoS One. 2012;7:e46779
-
(2012)
PLoS One
, vol.7
-
-
Badiger, R.1
Mitchell, J.A.2
Gashaw, H.3
Galloway-Phillipps, N.A.4
Foser, S.5
Tatsch, F.6
Singer, T.7
Hansel, T.T.8
Manigold, T.9
-
28
-
-
0033734698
-
The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells
-
Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD. The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol. 2000;36:S410-S413
-
(2000)
J Cardiovasc Pharmacol
, vol.36
-
-
Wort, S.J.1
Mitchell, J.A.2
Woods, M.3
Evans, T.W.4
Warner, T.D.5
-
29
-
-
77956390581
-
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
-
Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122:920-927
-
(2010)
Circulation
, vol.122
, pp. 920-927
-
-
Soon, E.1
Holmes, A.M.2
Treacy, C.M.3
Doughty, N.J.4
Southgate, L.5
Machado, R.D.6
Trembath, R.C.7
Jennings, S.8
Barker, L.9
Nicklin, P.10
Walker, C.11
Budd, D.C.12
Pepke-Zaba, J.13
Morrell, N.W.14
-
30
-
-
77957914450
-
Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury
-
Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One. 2010;5:e12106
-
(2010)
PLoS One
, vol.5
-
-
Pendergrass, S.A.1
Hayes, E.2
Farina, G.3
Lemaire, R.4
Farber, H.W.5
Whitfield, M.L.6
Lafyatis, R.7
-
31
-
-
34248389766
-
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
-
Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, Capron F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol. 2007;38:893-902
-
(2007)
Hum Pathol
, vol.38
, pp. 893-902
-
-
Dorfmüller, P.1
Humbert, M.2
Perros, F.3
Sanchez, O.4
Simonneau, G.5
Müller, K.M.6
Capron, F.7
-
32
-
-
69249145284
-
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy
-
Overbeek MJ, Vonk MC, Boonstra A, Voskuyl AE, Vonk-Noordegraaf A, Smit EF, Dijkmans BA, Postmus PE, Mooi WJ, Heijdra Y, Grünberg K. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. Eur Respir J. 2009;34:371-379
-
(2009)
Eur Respir J.
, vol.34
, pp. 371-379
-
-
Overbeek, M.J.1
Vonk, M.C.2
Boonstra, A.3
Voskuyl, A.E.4
Vonk-Noordegraaf, A.5
Smit, E.F.6
Dijkmans, B.A.7
Postmus, P.E.8
Mooi, W.J.9
Heijdra, Y.10
Grünberg, K.11
-
33
-
-
84883146392
-
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
-
de Weerd NA, Vivian JP, Nguyen TK, Mangan NE, Gould JA, Braniff SJ, Zaker-Tabrizi L, Fung KY, Forster SC, Beddoe T, Reid HH, Rossjohn J, Hertzog PJ. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat Immunol. 2013;14:901-907
-
(2013)
Nat Immunol
, vol.14
, pp. 901-907
-
-
De Weerd, N.A.1
Vivian, J.P.2
Nguyen, T.K.3
Mangan, N.E.4
Gould, J.A.5
Braniff, S.J.6
Zaker-Tabrizi, L.7
Fung, K.Y.8
Forster, S.C.9
Beddoe, T.10
Reid, H.H.11
Rossjohn, J.12
Hertzog, P.J.13
-
34
-
-
79955653358
-
IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension
-
Tsushima K, Osawa T, Yanai H, Nakajima A, Takaoka A, Manabe I, Ohba Y, Imai Y, Taniguchi T, Nagai R. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension. FASEB J. 2011;25:1531-1543
-
(2011)
FASEB J.
, vol.25
, pp. 1531-1543
-
-
Tsushima, K.1
Osawa, T.2
Yanai, H.3
Nakajima, A.4
Takaoka, A.5
Manabe, I.6
Ohba, Y.7
Imai, Y.8
Taniguchi, T.9
Nagai, R.10
-
35
-
-
0031629290
-
Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model
-
Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S541-S544
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, Issue.SUPPL. 1
-
-
Shindo, T.1
Kurihara, H.2
Kurihara, Y.3
Morita, H.4
Yazaki, Y.5
-
36
-
-
33646185492
-
Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
-
Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. 2006;80:4501-4509
-
(2006)
J Virol
, vol.80
, pp. 4501-4509
-
-
Ank, N.1
West, H.2
Bartholdy, C.3
Eriksson, K.4
Thomsen, A.R.5
Paludan, S.R.6
-
38
-
-
0029155792
-
Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis
-
Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol. 1995;155:3877-3888
-
(1995)
J Immunol
, vol.155
, pp. 3877-3888
-
-
Taub, D.D.1
Sayers, T.J.2
Carter, C.R.3
Ortaldo, J.R.4
-
39
-
-
0035024450
-
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
-
Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, Loy M, Binotto G, Valente M, Trentin L, Semenzato G. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol. 2001; 158:1703-1711
-
(2001)
Am J Pathol
, vol.158
, pp. 1703-1711
-
-
Agostini, C.1
Calabrese, F.2
Rea, F.3
Facco, M.4
Tosoni, A.5
Loy, M.6
Binotto, G.7
Valente, M.8
Trentin, L.9
Semenzato, G.10
-
40
-
-
84865192319
-
Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction
-
Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, Bálint Z, Olschewski A. Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One. 2012;7:e43793
-
(2012)
PLoS One
, vol.7
-
-
Zabini, D.1
Nagaraj, C.2
Stacher, E.3
Lang, I.M.4
Nierlich, P.5
Klepetko, W.6
Heinemann, A.7
Olschewski, H.8
Bálint, Z.9
Olschewski, A.10
-
41
-
-
0034700234
-
Tumor necrosis factor-Alpha promotes in vitro calcification of vascular cells via the cAMP pathway
-
Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-Alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636-2642
-
(2000)
Circulation
, vol.102
, pp. 2636-2642
-
-
Tintut, Y.1
Patel, J.2
Parhami, F.3
Demer, L.L.4
-
42
-
-
0034642570
-
Interferon-gamma elicits arteriosclerosis in the absence of leukocytes
-
Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207-211
-
(2000)
Nature
, vol.403
, pp. 207-211
-
-
Tellides, G.1
Tereb, D.A.2
Kirkiles-Smith, N.C.3
Kim, R.W.4
Wilson, J.H.5
Schechner, J.S.6
Lorber, M.I.7
Pober, J.S.8
-
43
-
-
43049177588
-
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
-
Prinz M, Schmidt H, Mildner A, et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 2008;28:675-686
-
(2008)
Immunity
, vol.28
, pp. 675-686
-
-
Prinz, M.1
Schmidt, H.2
Mildner, A.3
-
44
-
-
0019402302
-
Pharmacokinetic studies of interferons
-
Bocci V. Pharmacokinetic studies of interferons. Pharmacol Ther. 1981;13:421-440
-
(1981)
Pharmacol Ther
, vol.13
, pp. 421-440
-
-
Bocci, V.1
-
45
-
-
33846255059
-
Identification of genes selectively regulated by IFNs in endothelial cells
-
Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, Ferrari N, Anfosso L, Dell'Eva R, Noonan DM, Chieco-Bianchi L, Albini A, Amadori A. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol. 2007;178:1122-1135
-
(2007)
J Immunol
, vol.178
, pp. 1122-1135
-
-
Indraccolo, S.1
Pfeffer, U.2
Minuzzo, S.3
Esposito, G.4
Roni, V.5
Mandruzzato, S.6
Ferrari, N.7
Anfosso, L.8
Dell'Eva, R.9
Noonan, D.M.10
Chieco-Bianchi, L.11
Albini, A.12
Amadori, A.13
-
46
-
-
0031644535
-
Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells
-
Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD. Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S348-S350
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, Issue.SUPPL. 1
-
-
Woods, M.1
Bishop-Bailey, D.2
Pepper, J.R.3
Evans, T.W.4
Mitchell, J.A.5
Warner, T.D.6
-
47
-
-
33749345684
-
Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms
-
Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res. 2006;99:675-691
-
(2006)
Circ Res
, vol.99
, pp. 675-691
-
-
Stenmark, K.R.1
Fagan, K.A.2
Frid, M.G.3
|